Investing Profile

Lucio Iannone

InvestorVC
Vice President at Leaps by Bayer
leaps.bayer.com/teamCambridge, Massachusetts
Photo of Lucio Iannone, Vice President at Leaps by Bayer

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Leaps by Bayer Vice President
$100K - $5.0M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
EGenesis
Series DSep 2024$190M
Series CMar 2021$130M
Series BNov 2019$100M
$450M
Co-investors: Peter Hebert (Lux Capital), Isaac Ciechanover (Polaris Partners), Boris Nikolic (Biomatics Capital Partners), Steven Gillis (ARCH Venture Partners)
Paratus Sciences
Series AFeb 2023$100M
$100M
Leaps by Bayer
Series UnknownJan 2022
Mozart Therapeutics
Series AOct 2021$55M
$55M
Co-investors: Henrijette Richter (Soffinova Partners), Peter Dudek (MRL Ventures Fund), Steven Gillis (ARCH Venture Partners)
Immunitas Therapeutics
Series BAug 2021$58M
$97M
Co-investors: Laura Brass (Novartis Venture Fund), Daniel Coley (Cofounders Capital), Geeta Vemuri (Agent Capital), Brian Halak (Domain Associates), Christoph Westphal (Longwood Fund)